Latest Period
Q4 2025
Security Snapshot
Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share (QNRX) Institutional Ownership
CUSIP: 74907L409
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
18
Shares (Excl. Options)
842,827
Price
$14.43
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share
- Symbol
- QNRX on Nasdaq
- Shares outstanding
- 1,802,885
- Price per share
- $5.92
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 842,827
- Total reported value
- $12,161,983
- % of total 13F portfolios
- 0%
- Share change
- +841,336
- Value change
- +$12,140,475
- Number of holders
- 18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share is tracked under CUSIP 74907L409.
- 18 institutions reported positions in Q4 2025.
- 8 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 18 to 4 between Q4 2025 and Q1 2026.
- Reported value moved from $12,161,983 to $842,965.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 18 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 74907L409?
CUSIP 74907L409 identifies QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74907L409:
Significant Owners of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share (QNRX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 11% | +7% | $47,201,973 | +$3,465,711 | 3,271,100 | +7.9% | Stonepine Capital Management, LLC | 29 Jan 2026 |
| Woodline Partners LP | 9.5% | $38,298,838 | 2,785,370 | Woodline Partners LP | 31 Dec 2025 | |||
| INTEGRATED CORE STRATEGIES (US) LLC | 4.6% | -49% | $36,005,681 | +$9,858,888 | 2,618,595 | +38% | Integrated Core Strategies (US) LLC | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC | 5% | $7,049,313 | 1,081,183 | Armistice Capital, LLC | 31 Mar 2025 | |||
| Ikarian Capital, LLC | 13% | -50% | $3,052,472 | 211,538 | 0% | Ikarian Capital, LLC | 31 Jan 2026 | |
| Aberdeen Group plc | 4.2% | -53% | $491,250 | 75,000 | 0% | Aberdeen Group plc | 01 Apr 2026 | |
| ADAR1 Capital Management, LLC | 6.9% | $483,309 | 58,230 | ADAR1 Capital Management, LLC | 31 Dec 2025 | |||
| Resolute Capital Asset Partners LLC | 8.5% | $671,000 | 50,000 | Resolute Capital Asset Partners LLC | 10 Oct 2025 |
As of 31 Dec 2025, 18 institutional investors reported holding 842,827 shares of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share (QNRX). This represents 47% of the company’s total 1,802,885 outstanding shares.
Top 18 Institutional Shareholders
The largest institutional shareholders of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share (QNRX) together control 47% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 12% | 211,538 | 0.4% | $3,052,493 | |
| Woodline Partners LP | 4.4% | 79,582 | 0% | $1,148,368 | |
| Stonepine Capital Management, LLC | 4.3% | 78,189 | 0.9% | $1,128,267 | |
| Aberdeen Group plc | 4.2% | 75,000 | 0% | $1,082,250 | |
| MILLENNIUM MANAGEMENT LLC | 4.1% | 74,817 | 0% | $1,079,609 | |
| SummitTX Capital, L.P. | 3.6% | 64,795 | 0.03% | $934,992 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 3.3% | 59,838 | 0.02% | $863,462 | |
| ADAR1 Capital Management, LLC | 3.2% | 58,230 | 0.06% | $840,259 | |
| AIGH Capital Management LLC | 2.7% | 49,323 | 0.21% | $711,731 | |
| Resolute Capital Asset Partners LLC | 1.7% | 30,000 | 0.21% | $432,900 | |
| Soleus Capital Management, L.P. | 1.4% | 25,000 | 0.02% | $360,750 | |
| Simplify Asset Management Inc. | 0.97% | 17,448 | 0% | $251,775 | |
| Centiva Capital, LP | 0.67% | 12,053 | 0.01% | $173,925 | |
| MORGAN STANLEY | 0.17% | 3,000 | 0% | $43,290 | |
| GAMMA Investing LLC | 0.12% | 2,084 | +650% | 0% | $30,072 |
| RHUMBLINE ADVISERS | 0.09% | 1,666 | +38% | 0% | $24,031 |
| SBI Securities Co., Ltd. | 0.01% | 247 | +12250% | 0% | $3,564 |
| UBS Group AG | 0% | 17 | +1600% | 0% | $245 |